LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 31.55 | 771.67 | 1810 | 3196 | 0.5662 | 0.5155 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.78 | 771.67 | 1511 | 3499 | 0.4318 | 0.3608 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.78 | 771.67 | 1819 | 3499 | 0.5198 | 0.4816 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.00 | 771.67 | 1526 | 3884 | 0.3928 | 0.3397 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.00 | 771.67 | 1807 | 3884 | 0.4652 | 0.4404 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.22 | 771.67 | 1545 | 4299 | 0.3593 | 0.3233 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.22 | 771.67 | 1802 | 4299 | 0.4191 | 0.4081 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.44 | 771.67 | 1550 | 4738 | 0.3271 | 0.3052 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.44 | 771.67 | 1789 | 4738 | 0.3776 | 0.3787 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 42.67 | 771.67 | 1571 | 5155 | 0.3047 | 0.2962 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 42.67 | 771.67 | 1824 | 5155 | 0.3538 | 0.3688 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 44.89 | 771.67 | 1535 | 5541 | 0.2770 | 0.2735 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 44.89 | 771.67 | 1832 | 5541 | 0.3306 | 0.3553 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 47.11 | 771.67 | 1557 | 5941 | 0.2621 | 0.2692 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 47.11 | 771.67 | 1828 | 5941 | 0.3077 | 0.3403 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 49.33 | 771.67 | 1596 | 6392 | 0.2497 | 0.2690 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 49.33 | 771.67 | 1826 | 6392 | 0.2856 | 0.3263 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 51.55 | 771.67 | 1586 | 6829 | 0.2322 | 0.2574 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 51.55 | 771.67 | 1827 | 6829 | 0.2675 | 0.3152 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.77 | 771.67 | 1596 | 7256 | 0.2199 | 0.2520 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.77 | 771.67 | 1841 | 7256 | 0.2537 | 0.3086 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.99 | 771.67 | 1598 | 7690 | 0.2078 | 0.2454 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.99 | 771.67 | 1878 | 7690 | 0.2442 | 0.3075 | MN20160304_L01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.21 | 771.67 | 1612 | 8085 | 0.1994 | 0.2428 | MN20160304_L01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 58.21 | 771.67 | 1882 | 8085 | 0.2328 | 0.3009 | MN20160304_L01 | L05 |